ONCOLYTICS BIOTECH INC — Director's Dealing 2026

Jan 2, 2026

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ONCOLYTICS BIOTECH INC (ONCY)
CIK: 0001129928
Period of Report: 2026-01-01

Reporting Person: Look Kirk (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	275515	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$2.66	2027-01-16	Common Shares (31578)		Direct
Stock Option	$3.40	2026-03-08	Common Shares (155000)		Direct
Stock Option	$2.31	2026-12-09	Common Shares (80000)		Direct
Stock Option	$2.76	2028-08-15	Common Shares (105000)		Direct
Stock Option	$1.91	2028-12-08	Common Shares (231700)		Direct
Stock Option	$1.13	2029-12-18	Common Shares (243600)		Direct
Stock Option	$1.08	2030-08-15	Common Shares (570000)		Direct
Stock Option	$0.99	2030-12-15	Common Shares (250000)		Direct

Footnotes

F1: Includes 116,050 shares of restricted stock.

F2: The stock option is fully vested and exercisable.

F3: The exercise price is listed in Canadian dollars.

F4: The stock option vests in three equal annual installments beginning on December 18, 2024.

F5: The stock option vests in three equal annual installments beginning on August 15, 2026.

F6: The stock option vests in three equal annual installments beginning on December 15, 2026.